Refractory chronic lymphocytic leukemia with concomitant extramedullary multiple myeloma with lymph node involvement

Concomitant chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) in the same patient is extremely rare. In this report, we present an unprecedented case of a patient with a history of progressive, purine analog-resistant CLL, who developed extramedullary malignant plasmacytic infiltrates in lymph nodes on the background of preexisting CLL lesions, presenting with clinical sequelae attributable to active MM (hypercalcemia, renal insufficiency, anemia, bone lesions). We administered R-CHOP with bortezomib with partial remission and both CLL and MM relapsed after one month. Our patient deceased three months later. Surprisingly first bone marrow trephine biopsy did not reveal plasmacytic infiltration. However combination of symptoms presented by our patient should always be an indication for repeating biopsy. Early detection of aggressive multiple myeloma can improve prognosis and prolong survival.

Authors

Institutions

Publication Details

Journal
Current Problems in Cancer Case Reports
Published
2024-10-18
DOI
https://doi.org/10.1016/j.cpccr.2024.100324
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refractory chronic lymphocytic leukemia with concomitant extramedullary multiple myeloma with lymph node involvement

Laretta Grabowska-Derlatka, Barbara Wróblewska, Mateusz Ziarkiewicz, Grzegorz Władysław Basak et al.
Current Problems in Cancer Case Reports
Chronic Lymphocytic Leukemia Research
article

Refractory chronic lymphocytic leukemia with concomitant extramedullary multiple myeloma with lymph node involvement

Laretta Grabowska-Derlatka, Barbara Wróblewska, Mateusz Ziarkiewicz, Grzegorz Władysław Basak, Piotr Jachimowski, Łukasz Ciulkiewicz
article en

Abstract

Concomitant chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) in the same patient is extremely rare. In this report, we present an unprecedented case of a patient with a history of progressive, purine analog-resistant CLL, who developed extramedullary malignant plasmacytic infiltrates in lymph nodes on the background of preexisting CLL lesions, presenting with clinical sequelae attributable to active MM (hypercalcemia, renal insufficiency, anemia, bone lesions). We administered R-CHOP with bortezomib with partial remission and both CLL and MM relapsed after one month. Our patient deceased three months later. Surprisingly first bone marrow trephine biopsy did not reveal plasmacytic infiltration. However combination of symptoms presented by our patient should always be an indication for repeating biopsy. Early detection of aggressive multiple myeloma can improve prognosis and prolong survival.

Current Problems in Cancer Case ReportsVol. 16
Medical University of Warsaw (PL)
Good health and well-being
Openalex Percentile: Top 69%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.